MD Financial Management’s West Pharmaceutical WST Stock Holding History

MD Financial Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$3.29M	Buy	+7,015	New	+$3.02M	0.08%	90

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MD Financial Management's WST Position: Q4 2021 in Review

MD Financial Management opened a new position in West Pharmaceutical (WST) in Q4 2021: 7,015 shares worth $3.29M. The stake represents 0.08% of the portfolio and ranks #90 among its holdings.

729 funds tracked by Wall St. Rank hold WST as of Q4 2021.

MD Financial Management held 7,015 shares of West Pharmaceutical worth $3.29M as of Q4 2021.
West Pharmaceutical was a new MD Financial Management position in Q4 2021.
West Pharmaceutical made up 0.08% of MD Financial Management's portfolio in Q4 2021, its #90 holding.
729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on MD Financial Management's 13F filing for Q4 2021, filed 14 Feb 2022.